XML 52 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Net revenues $ 7,726 $ 7,531 $ 7,402
Operating costs and expenses and other operating (income) expense:      
Cost of services 5,037 4,926 4,719
Selling, general and administrative 1,457 1,424 1,443
Amortization of intangible assets 96 90 74
Other operating (income) expense, net (95) (10) 1
Total operating costs and expenses, net 6,495 6,430 6,237
Operating income 1,231 1,101 1,165
Other (expense) income:      
Interest expense, net (175) (167) (151)
Other income (expense), net 20 (8) 16
Total non-operating expenses, net (155) (175) (135)
Income from continuing operations before income taxes and equity in earnings of equity method investees 1,076 926 1,030
Income tax expense (247) (182) (241)
Equity in earnings of equity method investees, net of taxes 57 44 35
Income from continuing operations 886 788 824
Income from discontinued operations, net of taxes 20 0 0
Net income 906 788 824
Less: Net income attributable to noncontrolling interests 48 52 52
Net income attributable to Quest Diagnostics 858 736 772
Amounts attributable to Quest Diagnostics’ common stockholders:      
Income from continuing operations 838 736 772
Income from discontinued operations, net of taxes 20 0 0
Net income attributable to Quest Diagnostics $ 858 $ 736 $ 772
Earnings per share attributable to Quest Diagnostics’ common stockholders - basic:      
Income from continuing operations (in dollars per share) $ 6.21 $ 5.39 $ 5.63
Income from discontinued operations (in dollars per share) 0.15 0 0
Net income (in dollars per share) 6.36 5.39 5.63
Earnings per share attributable to Quest Diagnostics’ common stockholders - diluted:      
Income from continuing operations (in dollars per share) 6.13 5.29 5.50
Income from discontinued operations (in dollars per share) 0.15 0 0
Net income (in dollars per share) $ 6.28 $ 5.29 $ 5.50